Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 16/20 | 0.57 |
| ▸ | BIRC3 | Q13489 | 2/20 | 0.52 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.52 |
| ▸ | BIRC7 | Q96CA5 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10081371 | 0.93 | XIAP (0.65) | XIAPBIRC3BIRC2BIRC7 | |
| SCHEMBL3439008 | 0.91 | XIAP (0.52) | XIAPBIRC3BIRC2OPRM1 | |
| SCHEMBL13119703 | 0.91 | XIAP (0.53) | XIAPBIRC3BIRC2BIRC7 | |
| SCHEMBL3439047 | 0.90 | XIAP (0.53) | XIAPBIRC3BIRC2BIRC7OPRM1 | |
| SCHEMBL10081729 | 0.89 | XIAP (0.66) | XIAPBIRC3BIRC2BIRC7 | |
| SCHEMBL10066064 | 0.88 | XIAP (0.55) | XIAPBIRC3BIRC2 | |
| SCHEMBL10066062 | 0.87 | XIAP (0.55) | XIAPBIRC3BIRC2 | |
| SCHEMBL10081797 | 0.87 | XIAP (0.55) | XIAPBIRC3BIRC2 | |
| SCHEMBL10066066 | 0.87 | XIAP (0.60) | XIAPBIRC3BIRC2BIRC7 | |
| SCHEMBL10066056 | 0.86 | XIAP (0.48) | XIAPBIRC3BIRC2BIRC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586542-B2 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-20130281385-A1 | SMALL MOLECULE APOPTOSIS PROMOTERS | JOYANT PHARMACEUTICALS, INC. | 2013-10-24 | — | — | US | disclosed |
| US-8222291-B2 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20120082640-A1 | Small molecule apoptosis promoters | JOYANT PHARMACEUTICALS, INC. | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281385-A1 | SMALL MOLECULE APOPTOSIS PROMOTERS | BID, BAD, BAX | XIAP 31/4885BIRC3 7/4885BIRC2 11/4885 |
| US-20120082640-A1 | Small molecule apoptosis promoters | BID, BAD, BAX | XIAP 31/4885BIRC3 7/4885BIRC2 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.